Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Announces Integration of Therimmune; VP to Step Down

NEW YORK (GenomeWeb News) Oct. 1 - Gene Logic said today that it has reorganized its information services and contract study services business following its acquisition, last April of TherImmune Research.


As part of the reorganization, the company said it will no longer use the TherImmune Research Corporation name,a nd that all service offerings to pharmaceutical and biotechnology companies will be marketed under the Gene Logic name.


As part of this integration, Steve Trevisan, executive vice president and a director of the company, will step down, but will continue "in an advisory capacity" until the end of the year.


Trevisan was formerly president and CEO of TherImmune Research, and came on board at Gene Logic when the company  acquired TherImmune in April of this year.


The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.